What to do about orchestrated email campaigns: authors, editors, publishers, advertisers, and shareholders should ignore them.

Bibliographic Details
Published in:BMJ: British Medical Journal (Overseas & Retired Doctors Edition) pp. 491 - 493
Main Authors: Delamothe D, Godlee F
Format: editorial Journal Article
Published: BMJ Publishing Group 2/28/2009
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105481612&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105481612
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17592151
        BLM8
      jtl: BMJ: British Medical Journal (Overseas & Retired Doctors Edition)
      issn: 17592151
      maglogo: N
    pubinfo:
      dt: 2/28/2009
      pid: 8280
      pub: BMJ Publishing Group
    artinfo:
      ui:
        105481612
        105481612
        2010227426
        105481612
      ppf: 491
      ppct: 2
      formats:
      tig:
        atl: What to do about orchestrated email campaigns: authors, editors, publishers, advertisers, and shareholders should ignore them.
      aug:
        au:
          Delamothe D
          Godlee F
      sug:
        subj:
          Email Evaluation
          Politics
          United Kingdom
      pubtype: Academic Journal
      doctype:
        editorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N